Pfizer (PFE)
25.26
-1.01 (3.84%)
Upcoming Events
Latest Headlines
Pfizer (PFE) Declares $0.42 Quarterly Dividend; 6.4% Yield
April 24, 2024 4:37 PM - StreetInsider
Pfizer Declares Second-Quarter 2024 Dividend
April 24, 2024 4:37 PM - BizWire
Threshold to make it into the Top 100 biggest global companies is now at $141B - report
April 22, 2024 11:09 AM - StreetInsider
Pfizer (PFE) Announces EC Approves EMBLAVEO for Patients with Multidrug-Resistant Infections and Limited Treatment Options
April 22, 2024 8:08 AM - StreetInsider
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
April 22, 2024 8:08 AM - BizWire
Pfizer (PFE) drops to 11-year lows
April 17, 2024 12:00 PM - StreetInsider
Form 4 PFIZER INC For: Apr 15 Filed by: BOURLA ALBERT
April 16, 2024 1:50 PM - SEC Filing
Form 4 PFIZER INC For: Apr 15 Filed by: DAMICO JENNIFER B.
April 16, 2024 1:50 PM - SEC Filing
Form PX14A6G PFIZER INC Filed by: Tara Health Foundation
April 16, 2024 10:20 AM - SEC Filing
Popular stocks with increasing volume: RIVN PLTR INTC BAC NIO C PFE DJT MU COIN
April 16, 2024 4:26 AM - StreetInsider
Form 4 PFIZER INC For: Apr 10 Filed by: DAMICO JENNIFER B.
April 11, 2024 2:52 PM - SEC Filing
Form 4 PFIZER INC For: Apr 10 Filed by: BOURLA ALBERT
April 11, 2024 2:52 PM - SEC Filing
Form DEFA14A PFIZER INC
April 11, 2024 11:01 AM - SEC Filing
Form DEFA14A PFIZER INC
April 11, 2024 10:59 AM - SEC Filing
Form DEFA14A PFIZER INC
April 11, 2024 10:58 AM - SEC Filing
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
April 11, 2024 10:00 AM - BizWire
Moderna jumps as vaccine shows benefit in head and neck cancer in early study
April 9, 2024 11:26 AM - StreetInsider
2 reasons why Moderna stock is surging today
April 9, 2024 11:02 AM - StreetInsider
Form DEFA14A PFIZER INC
April 9, 2024 10:30 AM - SEC Filing
Moderna (MRNA) Climbs 9.4%
April 9, 2024 10:05 AM - StreetInsider
Midday movers: Coinbase falls; Pfizer and Moderna rise
April 9, 2024 8:13 AM - StreetInsider
Pfizer RSV shot meets goals in trial of high-risk adults under age 60
April 9, 2024 6:47 AM - StreetInsider
Pfizer (PFE) Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO in Adults Aged 18 to 59 at Increased Risk for RSV Disease
April 9, 2024 6:45 AM - StreetInsider
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
April 9, 2024 6:45 AM - BizWire
ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering Manager
April 8, 2024 12:45 PM - PR NewsWire
ViiV Healthcare announces U.S. FDA approval of Dovato for adolescents living with HIV (GSK) (PFE)
April 8, 2024 8:26 AM - StreetInsider
ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
April 8, 2024 8:23 AM - BizWire
Form 4 PFIZER INC For: Mar 28 Filed by: DAMICO JENNIFER B.
April 1, 2024 7:45 PM - SEC Filing
Form 4 PFIZER INC For: Mar 28 Filed by: BOURLA ALBERT
April 1, 2024 7:34 PM - SEC Filing
Form 4 PFIZER INC For: Mar 28 Filed by: SMITH JAMES C
April 1, 2024 1:33 PM - SEC Filing
Form 4 PFIZER INC For: Mar 28 Filed by: Echevarria Joseph
April 1, 2024 1:33 PM - SEC Filing
Form 4 PFIZER INC For: Mar 28 Filed by: Quincey James
April 1, 2024 1:33 PM - SEC Filing
Form 4 PFIZER INC For: Mar 28 Filed by: NARAYEN SHANTANU
April 1, 2024 1:33 PM - SEC Filing
Form DEFA14A PFIZER INC
March 28, 2024 4:23 PM - SEC Filing
Form DEFA14A PFIZER INC
March 28, 2024 4:12 PM - SEC Filing
Argus downgrades Pfizer (PFE), lowers earnings estimates on 'near-term headwinds'
March 22, 2024 9:42 AM - StreetInsider
Argus Downgrades Pfizer (PFE) to Hold, 'faces near-term headwinds to top-line growth'
March 22, 2024 7:04 AM - StreetInsider
Pfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with Analysts
March 20, 2024 10:00 AM - BizWire
Midday movers: Nvidia, Coinbase fall; Unilever rises
March 19, 2024 8:08 AM - StreetInsider
BOJ hike, Fed meeting, Nvidia conference, Bitcoin - what's moving markets
March 19, 2024 5:55 AM - StreetInsider
Pfizer offloads $3.5 billion stake in Sensodyne-maker Haleon
March 19, 2024 4:24 AM - StreetInsider
Form 4 PFIZER INC For: Mar 15 Filed by: DAMICO JENNIFER B.
March 18, 2024 6:40 PM - SEC Filing
Form 4 PFIZER INC For: Mar 15 Filed by: BOURLA ALBERT
March 18, 2024 6:40 PM - SEC Filing
Pfizer (PFE) to trim its Haleon stake to 24%
March 18, 2024 5:24 AM - StreetInsider
Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%
March 18, 2024 3:09 AM - StreetInsider
Form ARS PFIZER INC For: Dec 31
March 14, 2024 9:13 AM - SEC Filing
Pfizer (PFE) CEO Albert Bourla's 2023 Total Compensation $21.6M, Down from $33M In 2022
March 14, 2024 9:08 AM - StreetInsider
Form DEFA14A PFIZER INC
March 14, 2024 9:08 AM - SEC Filing
Form DEF 14A PFIZER INC For: Apr 25
March 14, 2024 9:05 AM - SEC Filing
Popular stocks with increasing volume: PLTR PYPL SQ FCX INTC BA SOUN COIN BABA PFE
March 14, 2024 4:34 AM - StreetInsider
European Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease
March 13, 2024 4:00 AM - BizWire
Pfizer (PFE) Reports Positive Overall Survival in Phase 3 Trial of ADCETRIS Regimen
March 12, 2024 6:46 AM - StreetInsider
Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
March 12, 2024 6:45 AM - BizWire
ViiV Healthcare Announces Interim Data at CROI Indicating Superior Efficacy of Long-Acting Injectable HIV Treatment Cabenuva (Cabotegravir + Rilpivirine) Compared to Daily Oral Therapy in Individuals
March 6, 2024 12:05 PM - BizWire
Form 4 PFIZER INC For: Mar 04 Filed by: BOURLA ALBERT
March 5, 2024 3:56 PM - SEC Filing
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
March 5, 2024 10:00 AM - BizWire
ViiV Healthcare and The American Academy of HIV Medicine Announce Fellowship to Improve HIV Prevention in Key Communities
March 5, 2024 8:48 AM - BizWire
ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses
March 4, 2024 1:50 PM - BizWire
Form 4 PFIZER INC For: Feb 28 Filed by: BOSHOFF CHRISTOFFEL
March 1, 2024 1:29 PM - SEC Filing
Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth
February 29, 2024 5:40 PM - BizWire
Pfizer (PFE) Reports Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO
February 29, 2024 8:01 AM - StreetInsider
Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
February 29, 2024 8:00 AM - BizWire
Form 4 PFIZER INC For: Feb 28 Filed by: Dolsten Mikael
February 29, 2024 6:54 AM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: SAHNI PAYAL
February 28, 2024 5:26 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: de Germay Alexandre
February 28, 2024 5:25 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: Denton David M
February 28, 2024 5:18 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: MALIK AAMIR
February 28, 2024 5:18 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: JOHNSON RADY A
February 28, 2024 5:18 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: LANKLER DOUGLAS M
February 28, 2024 5:18 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: McDermott Michael
February 28, 2024 5:18 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: Fonseca Lidia
February 28, 2024 5:11 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: BOSHOFF CHRISTOFFEL
February 28, 2024 5:11 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: SUSMAN SALLY
February 28, 2024 5:11 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: BOURLA ALBERT
February 28, 2024 5:11 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: Dolsten Mikael
February 28, 2024 5:11 PM - SEC Filing
Form 4 PFIZER INC For: Feb 27 Filed by: DAMICO JENNIFER B.
February 28, 2024 5:11 PM - SEC Filing
ViiV Healthcare to present data for its next generation of ultra long-acting treatments for HIV
February 28, 2024 10:04 AM - BizWire
Form 4 PFIZER INC For: Feb 23 Filed by: McDermott Michael
February 27, 2024 1:48 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: SAHNI PAYAL
February 27, 2024 1:47 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: SUSMAN SALLY
February 27, 2024 1:47 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: BOURLA ALBERT
February 27, 2024 1:47 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: Dolsten Mikael
February 27, 2024 1:47 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: JOHNSON RADY A
February 27, 2024 1:47 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: DAMICO JENNIFER B.
February 27, 2024 1:47 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: LANKLER DOUGLAS M
February 27, 2024 1:47 PM - SEC Filing
Form 4 PFIZER INC For: Feb 23 Filed by: BOSHOFF CHRISTOFFEL
February 27, 2024 1:44 PM - SEC Filing
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 26, 2024 10:00 AM - BizWire
Pfizer (PFE) Files Mixed Shelf
February 23, 2024 4:40 PM - StreetInsider
Form S-3ASR PFIZER INC
February 23, 2024 4:38 PM - SEC Filing
Form S-8 PFIZER INC
February 23, 2024 4:38 PM - SEC Filing
Popular stocks with increasing volume: PFE RIVN SMCI SQ CVNA WBD PANW MARA ARM
February 23, 2024 2:08 PM - StreetInsider
Pfizer (PFE) stock is a new Buy at Guggenheim
February 23, 2024 5:41 AM - StreetInsider
Guggenheim Starts Pfizer (PFE) at Buy, 'Successful Execution Can Drive Upside'
February 22, 2024 4:10 PM - StreetInsider
Form 10-K PFIZER INC For: Dec 31
February 22, 2024 1:19 PM - SEC Filing
Pfizer (PFE) Announces EU Approval of VELSIPITY
February 21, 2024 10:36 PM - StreetInsider
Everest Medicines' Partner Pfizer Announces European Commission Approves VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis
February 21, 2024 7:48 PM - PR NewsWire
Comprehensive study links COVID vaccines to rare but notable adverse effects
February 20, 2024 2:36 PM - StreetInsider
European Commission Approves Pfizer’s VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis
February 19, 2024 7:45 AM - BizWire
Form 4 PFIZER INC For: Feb 14 Filed by: BOURLA ALBERT
February 16, 2024 12:55 PM - SEC Filing
Form 4 PFIZER INC For: Feb 14 Filed by: DAMICO JENNIFER B.
February 16, 2024 12:53 PM - SEC Filing
Form 4 PFIZER INC For: Feb 14 Filed by: JOHNSON RADY A
February 16, 2024 12:52 PM - SEC Filing
Pfizer Invites Public to Register for Webcast of Pfizer Oncology Innovation Day
February 15, 2024 10:00 AM - BizWire
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024 8:45 AM - StreetInsider
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
February 14, 2024 8:30 AM - StreetInsider
Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer
February 14, 2024 8:00 AM - StreetInsider
Form SC 13G/A PFIZER INC Filed by: VANGUARD GROUP INC
February 13, 2024 6:00 PM - SEC Filing
ViiV Healthcare announces new packaging option now available in the U.S. for Dovato (dolutegravir/lamivudine)
February 6, 2024 6:47 PM - BizWire
Arvinas (ARVN) and Pfizer (PFE) Announce Vepdegestrant Granted FDA Fast Track Designation
February 6, 2024 6:46 AM - StreetInsider
Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer
February 6, 2024 6:45 AM - StreetInsider
ViiV Healthcare announces new packaging option now available in the U.S. for Dovato (dolutegravir/lamivudine)
February 5, 2024 11:00 AM - BizWire
Breaking Barriers in Cancer Care: The American Cancer Society and Pfizer Announce a $15 Million, Three-Year Initiative to Bridge the Gap in Cancer Care Disparities
February 5, 2024 10:00 AM - BizWire
Pfizer (PFE) PT Lowered to $28 at UBS
January 31, 2024 10:16 AM - StreetInsider
Pfizer (PFE) PT Lowered to $32 at DZ Bank
January 31, 2024 3:43 AM - StreetInsider
Form 8-K PFIZER INC For: Jan 30
January 30, 2024 8:04 AM - SEC Filing
Midday movers: GM advances, Apple declines, and more
January 30, 2024 7:58 AM - StreetInsider
Pfizer fourth-quarter loss shallower than anticipated
January 30, 2024 6:57 AM - StreetInsider
Pfizer posts surprise 4th quarter profit, but key products miss on sales
January 30, 2024 6:51 AM - StreetInsider
Pfizer (PFE) Tops Q4 EPS by 28c, Tops on Revenue; Offers Guidance
January 30, 2024 6:46 AM - StreetInsider
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
January 30, 2024 6:45 AM - BizWire
Form SC 13G/A PFIZER INC Filed by: STATE STREET CORP
January 29, 2024 1:05 PM - SEC Filing
Pfizer (PFE) February weekly option implied volatility elevated into quarter results
January 29, 2024 10:48 AM - StreetInsider
Pfizer (PFE): FDA Revises Letter of Authorization for the Emergency Use Authorization for Paxlovid
January 29, 2024 9:53 AM - StreetInsider
Dow Jones, Nasdaq, S&P 500 weekly preview: FOMC, NFP, Apple, Microsoft and more
January 29, 2024 9:16 AM - StreetInsider
Pfizer (PFE) February weekly 27.50 straddle priced into quarter results
January 29, 2024 4:09 AM - StreetInsider
Pfizer (PFE) Announces EMA Validates Type II Variation Application for PADCEV with KEYTRUDA for First-Line Treatment of Advanced Bladder Cancer
January 26, 2024 12:01 PM - StreetInsider
European Medicines Agency Validates Type II Variation Application for PADCEV™ (enfortumab vedotin) with KEYTRUDA®(pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
January 26, 2024 12:00 PM - PR NewsWire
European Medicines Agency Validates Type II Variation Application for PADCEV® (enfortumab vedotin) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
January 26, 2024 12:00 PM - BizWire
Form SC 13G/A PFIZER INC Filed by: BlackRock Inc.
January 26, 2024 11:53 AM - SEC Filing
Full Article List
